AKAP9 and breast carcinoma: In summary, in this very large case–control study focused on common candidate non-synonymous variants, we have identified a novel susceptibility locus at 3p21 and confirmed AKAP9-rs6964587 as a marker of a breast cancer risk at 7q21.